Trueblood Wealth Management’s Broadridge BR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$754K Sell
5,505
-1,054
-16% -$159K 0.26% 120
2026
Q1
$1.07M Sell
6,559
-173
-3% -$32.9K 0.42% 79
2025
Q4
$1.5M Sell
6,732
-201
-3% -$45.8K 0.59% 54
2025
Q3
$1.65M Sell
6,933
-96
-1% -$23.9K 0.64% 39
2025
Q2
$1.71M Sell
7,029
-1
-0% -$238 0.71% 33
2025
Q1
$1.7M Buy
7,030
+186
+3% +$43.8K 0.79% 29
2024
Q4
$1.55M Buy
6,844
+88
+1% +$19.7K 0.76% 27
2024
Q3
$1.45M Sell
6,756
-14
-0.2% -$2.93K 0.73% 32
2024
Q2
$1.33M Sell
6,770
-1
-0% -$198 0.75% 31
2024
Q1
$1.39M Sell
6,771
-200
-3% -$40.3K 0.79% 29
2023
Q4
$1.43M Buy
+6,971
New +$1.29M 0.9% 24

Other funds holding BR

Trueblood Wealth Management's BR Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Broadridge (BR) stake by 16% in Q2 2026, selling an estimated $159K and leaving 5,505 shares worth $754K. The position accounts for 0.26% of the portfolio, ranked #120.

Trueblood Wealth Management first reported a position in BR in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.71M in Q2 2025. 1,013 funds tracked by Wall St. Rank hold BR as of Q2 2026.

  • Trueblood Wealth Management held 5,505 shares of Broadridge worth $754K as of Q2 2026.
  • Trueblood Wealth Management sold 1,054 Broadridge shares in Q2 2026, an estimated $159K.
  • Broadridge made up 0.26% of Trueblood Wealth Management's portfolio in Q2 2026, its #120 holding.
  • Trueblood Wealth Management first reported a position in Broadridge in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Broadridge position peaked at $1.71M in Q2 2025.
  • 1,013 funds tracked by Wall St. Rank held Broadridge as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.